← FDA DRUG APPROVALS

FDA ANDA · ANDA087509

MEPIVACAINE HYDROCHLORIDE

Sponsor: INTL MEDICATION SYS

APPLICATION
ANDA087509
TYPE
ANDA
ORIGINAL APPROVAL
1982-10-05
LATEST ACTION
1998-01-14
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

MEPIVACAINE HYDROCHLORIDEDiscontinued
MEPIVACAINE HYDROCHLORIDE 1% · INJECTABLE · INJECTION

Approval history

1998-01-14Manufacturing (CMC) · Supplement 8AP
1995-09-19Manufacturing (CMC) · Supplement 10AP
1994-06-28Manufacturing (CMC) · Supplement 9AP
1993-10-29Manufacturing (CMC) · Supplement 7AP
1993-02-08Manufacturing (CMC) · Supplement 6AP
1992-05-07Labeling · Supplement 4AP
1990-08-02Labeling · Supplement 1AP
1990-08-02Labeling · Supplement 2AP
1988-12-13Manufacturing (CMC) · Supplement 3AP
1982-10-05OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →